Polypeptide Group Ag
Polypeptide Group Ag is a Private limited company (Ltd.) registered in Switzerland under CHE159266771, and its current status with Zefix — Swiss Central Business Names Index is active. The company was incorporated on 7 April 2021 and lists its registered address as Baar, Switzerland. 1 shareholder is on record for Polypeptide Group Ag, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Zefix — Swiss Central Business Names Index and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for Polypeptide Group Ag, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing.
The largest of these is SCHWAB STRATEGIC TRUST-Schwab International Small-Cap Equity ETF, holding 2.1% — the largest recorded stake.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| SCHWAB STRATEGIC TRUST-Schwab International Small-Cap Equity ETF | 2.1% | Zefix — Swiss Central Business Names Index |
Officers
5
The Executive Chair of Polypeptide Group Ag currently on record is Klaus Peter Wilden; five officers are currently on record for Polypeptide Group Ag, filed with Zefix — Swiss Central Business Names Index.
The register reports 20 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Polypeptide Group Ag sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Polypeptide Group Ag sits 4 levels below its ultimate parent, C&P Investors Limited, registered in British Virgin Islands. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. The full chain up to C&P Investors Limited is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Polypeptide Group Ag's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span Switzerland, United States, Sweden jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 2 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
C&P Investors Limited
British Virgin Islands
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Polypeptide Group Ag?
One shareholder is currently on record for Polypeptide Group Ag, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing. The largest of these is SCHWAB STRATEGIC TRUST-Schwab International Small-Cap Equity ETF, holding 2.1% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Polypeptide Group Ag's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Polypeptide Group Ag is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Polypeptide Group Ag have on record?
1 shareholder is shown on record for Polypeptide Group Ag.
What is Polypeptide Group Ag's company registration number?
Polypeptide Group Ag's registration number is CHE159266771, filed with Zefix — Swiss Central Business Names Index in Switzerland. Its current status on the register is active.
Is Polypeptide Group Ag still an active company?
Polypeptide Group Ag's status on Zefix — Swiss Central Business Names Index is listed as active.
When was Polypeptide Group Ag incorporated?
Polypeptide Group Ag was incorporated on 7 April 2021, according to Zefix — Swiss Central Business Names Index.
What is Polypeptide Group Ag's registered address?
The registered address on file for Polypeptide Group Ag is Baar, Switzerland.
What legal structure is Polypeptide Group Ag registered as?
Polypeptide Group Ag is registered as a Private limited company (Ltd.) in Switzerland.
Who are the officers/directors of Polypeptide Group Ag?
The Executive Chair of Polypeptide Group Ag currently on record is Klaus Peter Wilden; five officers are currently on record for Polypeptide Group Ag, filed with Zefix — Swiss Central Business Names Index. Management authority at Polypeptide Group Ag sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Polypeptide Group Ag have a parent company or subsidiaries?
Polypeptide Group Ag sits 4 levels below its ultimate parent, C&P Investors Limited, registered in British Virgin Islands. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. Those 2 subsidiaries span Switzerland, United States, Sweden jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 2 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Polypeptide Group Ag's ownership over time?
This profile reflects a point-in-time snapshot from Zefix — Swiss Central Business Names Index. Zavia's monitoring API can track changes to Polypeptide Group Ag's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Polypeptide Group Ag's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Switzerland, so records like Polypeptide Group Ag's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Zefix — Swiss Central Business Names Index and was last synced on 28 September 2026.